MP gene therapy production facility in Lexington, Massachusetts.

Original Release: https://www.globenewswire.com/news-release/2023/02/27/2615948/0/en/uniQure-Announces-2022-Financial-Results-and-Highlights-Recent-Company-Progress.html


<
Previous Post
CEO Proves to Short Seller: Ayurcann Defies Its Industry’s Struggles with Innovation and Efficiency.
>
Next Post
CEO’s Weird Promotion Encounter Results in Rearrangement of SEC Disclosure